NCT01080209 - Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System | Biotech Hunter

Enrollment

215

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Patients Who Participated in an Intravitreal Brimo PS DDS® Study

Interventions

DRUG

Brimo PS DDS®

Patients who received Brimo PS DDS® intravitreal implant in a previous study.

OTHER

Sham

Patients who recieved sham in a previous study.

Trial Locations (13)

Artesia

Sydney

Westmead

Brno

Paris

Karlsruhe

New Delhi

Tel Aviv

Udine

Makati

Coimbra

Seoul

London